Related references
Note: Only part of the references are listed.Tumors and Their Microenvironment Dual-Targeting Chemotherapy with Local Immune Adjuvant Therapy for Effective Antitumor Immunity against Breast Cancer
Caifeng Deng et al.
ADVANCED SCIENCE (2019)
cRGD target liposome delivery system promoted immunogenic cell death through enhanced anticancer potency of a thymidine conjugate under UVA activation as a cancer vaccine
Rong Yang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Bevacizumab-Based Chemotherapy Triggers Immunological Effects in Responding Multi-Treated Recurrent Ovarian Cancer Patients by Favoring the Recruitment of Effector T Cell Subsets
Chiara Napoletano et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Naphthyl quinoxaline thymidine conjugate is a potent anticancer agent post UVA activation and elicits marked inhibition of tumor growth through vaccination
Ying Yuan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Crizotinib-induced immunogenic cell death in non-small cell lung cancer
Peng Liu et al.
NATURE COMMUNICATIONS (2019)
Dual functional immunostimulatory polymeric prodrug carrier with pendent indoximod for enhanced cancer immunochemotherapy
Zhuoya Wan et al.
ACTA BIOMATERIALIA (2019)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway
Yu Liu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)
S. J. L. Mesnage et al.
ANNALS OF ONCOLOGY (2017)
Therapeutic Versatility of Resveratrol Derivatives
Waqas Nawaz et al.
NUTRIENTS (2017)
Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
Abhishek D. Garg et al.
ONCOIMMUNOLOGY (2017)
Cytokines in immunogenic cell death: Applications for cancer immunotherapy
Anne Showalter et al.
CYTOKINE (2017)
Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells
HyeRan Gwak et al.
CANCER LETTERS (2016)
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
Christina Pfirschke et al.
IMMUNITY (2016)
A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers
Krithika N. Kodumudi et al.
CLINICAL CANCER RESEARCH (2010)
Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy
Lei Zhang et al.
CLINICAL IMMUNOLOGY (2008)
Resveratrol-induced autophagocytosis in ovarian cancer cells
AW Opipari et al.
CANCER RESEARCH (2004)
Ovarian cancer: Strategies for overcoming resistance to chemotherapy
R Agarwal et al.
NATURE REVIEWS CANCER (2003)
Resveratrol suppresses hepatoma cell invasion independently of its anti-proliferative action
Y Kozuki et al.
CANCER LETTERS (2001)
Share Paper
